Home » General World News » A big drugmaker is backing away from a plan to triple the price of a lifesaving cancer drug after facing a public backlash

A big drugmaker is backing away from a plan to triple the price of a lifesaving cancer drug after facing a public backlash





FILE PHOTO: Pharmaceutical tablets and capsules are arranged on a table in this picture illustration taken in Ljubljana August 20, 2014.  REUTERS/Srdjan Zivulovic /File Photo

  • Drugmaker Pharmacyclics had tripled the cost of a lifesaving cancer blood treatment when it introduced a new version of the pill.
  • The new price tag faced criticism from cancer doctors who were concerned about how this would impact how they dosed patients with the drug.
  • Last week, Pharmacyclics reversed its decision to take the initial version of the drug off the market, giving patients and doctors a lower-cost option.

The maker of a lifesaving blood cancer treatment planned to triple the cost of the drug — but it’s backing down after pressure from doctors.

The drug, Imbruvica, treats serious forms of read more >>>

Source:: BusinessInsider.Com

Comments are closed.